Imaged parent items

News

Submitted by admin on Sun, 02/17/2008 - 00:00

High-Tech Study of MS Brain Specimens Uncovers Hundreds of Proteins That May Offer Clues to Future Treatment Approaches

Submitted by admin on Fri, 02/15/2008 - 00:00

MS Trials Alert - Single-Dose Experimental IV Drug “RTL1000” Recruiting MS Patients at Five Sites Nationwide

Submitted by admin on Thu, 02/14/2008 - 00:00

Dr. Mirjana Savatic of Stony Brook who has been able to visualize the marker of stem cells in the brain using magnetic resonance spectroscopy. Dr. Savatic is now collaborating with Dr. Lauren Krupp of Stony Brook to apply these methods.

Submitted by admin on Fri, 02/08/2008 - 00:00

Clinical Trial of Investigational, Once-Daily Oral FTY720 Recruiting Participants with MS across the U.S.

Submitted by admin on Thu, 02/07/2008 - 00:00

Two Cases of Melanoma (Skin Cancer) Reported in People Taking Tysabri for MS

Submitted by admin on Fri, 02/01/2008 - 00:00

Tysabri Label Changed To Reflect Potential Liver Damage

Submitted by admin on Fri, 01/25/2008 - 00:00

Genetic Differences May Predict Response to Interferon Treatment for MS

Submitted by admin on Wed, 01/09/2008 - 22:34

Pediatric MS December 2007 Newsletter

Submitted by admin on Fri, 12/14/2007 - 00:00

Great Strides Moved MS Research Forward During 2007

Submitted by admin on Fri, 12/07/2007 - 00:00

Study Suggests MS Drugs Delay Progression of Disability in Relapsing MS

Pages

Stony Brook University Hospital
101 Nicolls Road Stony Brook, NY 11794
(631) 444-4000